XML 25 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Ordinary shares
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jun. 30, 2024   186,367,686      
Beginning balance at Jun. 30, 2024 $ 1,097,471 $ 1,764,289 $ 51,286 $ (683,109) $ (34,994)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Ordinary shares – at-the-market offering, net of issuance costs (in shares)   9,138,867      
Issuance of Ordinary shares – at-the-market offering, net of issuance costs 73,145 $ 73,145      
Issuance of Ordinary shares – restricted stock units (in shares)   1,132,733      
Issuance of Ordinary shares – restricted stock units 4,758 $ 4,758      
Issuance of Ordinary shares – stock options (in shares)   490,196      
Issuance of Ordinary shares – stock options 991 $ 991      
Stock-based compensation 3,160   3,160    
Change in foreign currency translation adjustments 1,854       1,854
Net income (loss) (51,703)     (51,703)  
Ending balance (in shares) at Sep. 30, 2024   197,129,482      
Ending balance at Sep. 30, 2024 1,129,677 $ 1,843,183 54,446 (734,812) (33,140)
Beginning balance (in shares) at Jun. 30, 2024   186,367,686      
Beginning balance at Jun. 30, 2024 1,097,471 $ 1,764,289 51,286 (683,109) (34,994)
Ending balance (in shares) at Jun. 30, 2025   257,211,899      
Ending balance at Jun. 30, 2025 1,817,488 $ 2,355,056 88,672 (596,167) (30,073)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of Ordinary shares – at-the-market offering, net of issuance costs (in shares)   23,041,102      
Issuance of Ordinary shares – at-the-market offering, net of issuance costs 599,918 $ 599,918      
Issuance of Ordinary shares – restricted stock units (in shares)   314,237      
Issuance of Ordinary shares – restricted stock units 1,787 $ 1,787      
Issuance of Ordinary shares – stock options (in shares)   2,309,065      
Issuance of Ordinary shares – stock options 8,827 $ 8,827      
Stock-based compensation 68,994   68,994    
Change in foreign currency translation adjustments (5,458)       (5,458)
Net income (loss) 384,611     384,611  
Ending balance (in shares) at Sep. 30, 2025   282,876,303      
Ending balance at Sep. 30, 2025 $ 2,876,167 $ 2,965,588 $ 157,666 $ (211,556) $ (35,531)